We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Tompkins Financial
TMP
$1.45B
| $4.24M | 0.01% |
46,292
+1,771
| +4% | +$153K |
|
|
KW
1352
DELISTED
Kennedy-Wilson Holdings
KW
| $4.23M | 0.01% |
189,756
+4,579
| +2% | +$103K |
|
|
ZNGA
1353
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $4.23M | 0.01% |
690,979
+1,962
| +0.3% | +$12.1K |
|
1354
PTC Therapeutics
PTCT
$5.78B
| $4.22M | 0.01% |
87,963
+7,141
| +9% | +$303K |
|
1355
Central Garden & Pet Co Class A
CENTA
$2.41B
| $4.22M | 0.01% |
179,720
+7,685
| +4% | +$173K |
|
|
VRTU
1356
DELISTED
Virtusa Corporation
VRTU
| $4.21M | 0.01% |
92,928
+4,863
| +6% | +$198K |
|
|
ESGR
1357
DELISTED
Enstar Group
ESGR
| $4.2M | 0.01% |
20,307
+617
| +3% | +$123K |
|
1358
Cimpress
CMPR
$2.44B
| $4.2M | 0.01% |
33,353
-578
| -2% | -$75.1K |
|
|
RP
1359
DELISTED
RealPage, Inc.
RP
| $4.2M | 0.01% |
78,047
+1,387
| +2% | +$79.1K |
|
|
DCH
1360
Dauch Corp
DCH
$1.42B
| $4.19M | 0.01% |
389,418
+24,417
| +7% | +$232K |
|
1361
Cannae Holdings
CNNE
$654M
| $4.18M | 0.01% |
112,300
+1,730
| +2% | +$56.8K |
|
1362
AeroVironment
AVAV
$8.51B
| $4.17M | 0.01% |
67,584
+3,670
| +6% | +$220K |
|
|
WDR
1363
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $4.16M | 0.01% |
249,055
+8,271
| +3% | +$135K |
|
1364
Matthews International
MATW
$857M
| $4.16M | 0.01% |
108,863
+5,225
| +5% | +$192K |
|
|
LSXMA
1365
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $4.16M | 0.01% |
118,969
+1,016
| +0.9% | +$33.6K |
|
1366
WesBanco
WSBC
$4.04B
| $4.15M | 0.01% |
109,875
+23,723
| +28% | +$886K |
|
|
EVBG
1367
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $4.15M | 0.01% |
53,166
+1,954
| +4% | +$151K |
|
1368
AZZ Inc
AZZ
$4.57B
| $4.15M | 0.01% |
90,288
+4,407
| +5% | +$180K |
|
|
AIMC
1369
DELISTED
Altra Industrial Motion Corp
AIMC
| $4.13M | 0.01% |
113,982
+3,000
| +3% | +$95.3K |
|
1370
AXIS Capital
AXS
$7.61B
| $4.12M | 0.01% |
69,321
+478
| +0.7% | +$28.9K |
|
1371
Graphic Packaging
GPK
$3.52B
| $4.1M | 0.01% |
246,143
+4,673
| +2% | +$74.1K |
|
|
AVTA
1372
DELISTED
Avantax, Inc. Common Stock
AVTA
| $4.09M | 0.01% |
156,347
+8,869
| +6% | +$199K |
|
|
GCP
1373
DELISTED
GCP Applied Technologies Inc.
GCP
| $4.08M | 0.01% |
179,619
+8,656
| +5% | +$186K |
|
1374
Pathward Financial
CASH
$1.89B
| $4.07M | 0.01% |
111,487
+6,029
| +6% | +$205K |
|
1375
Herbalife
HLF
$1.31B
| $4.07M | 0.01% |
85,265
+1,244
| +1% | +$53.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.